Indirect airway challenges
- PMID: 12797503
- DOI: 10.1183/09031936.03.00008403
Indirect airway challenges
Erratum in
- Eur Respir J. 2003 Oct;22(4):718
Abstract
Indirect challenges act by causing the release of endogenous mediators that cause the airway smooth muscle to contract. This is in contrast to the direct challenges where agonists such as methacholine or histamine cause airflow limitation predominantly via a direct effect on airway smooth muscle. Direct airway challenges have been used widely and are well standardised. They are highly sensitive, but not specific to asthma and can be used to exclude current asthma in a clinic population. Indirect bronchial stimuli, in particular exercise, hyperventilation, hypertonic aerosols, as well as adenosine, may reflect more directly the ongoing airway inflammation and are therefore more specific to identify active asthma. They are increasingly used to evaluate the prevalence of bronchial hyperresponsiveness and to assess specific problems in patients with known asthma, e.g. exercise-induced bronchoconstriction, evaluation before scuba diving. Direct bronchial responsiveness is only slowly and to a modest extent, influenced by repeated administration of inhaled steroids. Indirect challenges may reflect more closely acute changes in airway inflammation and a change in responsiveness to an indirect stimulus may be a clinically relevant marker to assess the clinical course of asthma. Moreover, some of the indirect challenges, e.g. hypertonic saline and mannitol, can be combined with the assessment of inflammatory cells by induction of sputum.
Similar articles
-
Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance.Chest. 2010 Aug;138(2 Suppl):25S-30S. doi: 10.1378/chest.10-0116. Chest. 2010. PMID: 20668015 Review.
-
Bronchial hyperresponsiveness: too complex to be useful?Curr Opin Pharmacol. 2003 Jun;3(3):233-8. doi: 10.1016/s1471-4892(03)00046-8. Curr Opin Pharmacol. 2003. PMID: 12810185 Review.
-
Provoked models of asthma: what have we learnt?Clin Exp Allergy. 2009 Feb;39(2):181-92. doi: 10.1111/j.1365-2222.2008.03172.x. Clin Exp Allergy. 2009. PMID: 19187330 Review.
-
Challenge tests to assess airway hyperresponsiveness and efficacy of drugs used in the treatment of asthma.J Aerosol Med. 1996 Spring;9(1):95-109. doi: 10.1089/jam.1996.9.95. J Aerosol Med. 1996. PMID: 10184583 Review.
-
Diagnostic and therapeutic value of airway challenges in asthma.Curr Allergy Asthma Rep. 2009 May;9(3):247-53. doi: 10.1007/s11882-009-0036-z. Curr Allergy Asthma Rep. 2009. PMID: 19348726 Review.
Cited by
-
Role of cells and mediators in exercise-induced bronchoconstriction.Immunol Allergy Clin North Am. 2013 Aug;33(3):313-28, vii. doi: 10.1016/j.iac.2013.02.003. Epub 2013 Mar 29. Immunol Allergy Clin North Am. 2013. PMID: 23830127 Free PMC article. Review.
-
The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.Br J Pharmacol. 2005 Aug;145(8):1009-15. doi: 10.1038/sj.bjp.0706272. Br J Pharmacol. 2005. PMID: 15980878 Free PMC article.
-
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010 May 15;181(10):1049-60. doi: 10.1164/rccm.200906-0857OC. Epub 2010 Jan 28. Am J Respir Crit Care Med. 2010. PMID: 20110559 Free PMC article.
-
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.Br J Clin Pharmacol. 2021 Feb;87(2):483-493. doi: 10.1111/bcp.14406. Epub 2020 Jun 17. Br J Clin Pharmacol. 2021. PMID: 32484940 Free PMC article. Clinical Trial.
-
Bronchial provocation tests in clinical practice.Sao Paulo Med J. 2011;129(4):243-9. doi: 10.1590/s1516-31802011000400008. Sao Paulo Med J. 2011. PMID: 21971900 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical